RPB Stein Innovation Awards provide funds to vision researchers with a goal of understanding the visual system and the diseases that compromise its function. These awards are intended to provide seed money to proposed high-risk / high-gain vision science research which is innovative, cutting-edge, and demonstrates out-of-the-box thinking.
RPB offers two types of awards, a Stein Innovation Award inside ophthalmology and a Stein Innovation Award outside ophthalmology, depending on the primary appointment of faculty applying for this award:
The Stein Innovation Awards are not to serve as venture philanthropy for start-up companies. The application should also not be a natural extension of the candidate’s research progress to date; it should catalyze a new line of inquiry or otherwise show a departure from previously funded research. The proposed research in the application should provide a clear and rational research plan, compelling preliminary data, and careful consideration of pitfalls, which should be addressed in the candidate’s scientific statement. Additionally, the application should be substantially different than an R01-type research endeavor. The proposed research should be something that federal funders are not apt to finance due to its unconventional and novel reasoning.
Type
Individual
Amount
$300,000
Eligibility
Associate Professor, Professor
Duration
3 years
Status
Open
Deadline
Nomination Due: June 15 (outside ophthalmology) or December 15 (inside ophthalmology)
Application Due: July 1 (outside ophthalmology) or January 10 (inside ophthalmology)
RPB’s mission is to preserve and restore vision and prevent blindness by funding research that advances understanding, treatment, or prevention of vision-threatening conditions. Grants that clearly advance this mission — including basic, translational, and clinical research into eye diseases — are competitive.RPB USA
Predictor: A proposal that explicitly ties project goals to vision loss mechanisms, treatment innovation, or prevention strategies.
RPB supports research that is scientifically rigorous and has potential for major impact in vision science. Funded awards are intended to push the field forward and have been associated with breakthroughs in areas like retinal disease, amblyopia, and glaucoma.RPB USA
Predictor: A research plan with:
clear, important questions,
strong methodology,
compelling rationale for why results will matter.
For individual investigator grants (e.g., Career Development Award, Physician-Scientist Award, Stein Innovation Award), successful applicants typically have:
A solid scientific track record appropriate to career stage,
A productive research environment,
Mentorship and support from their department.RPB USA
Predictor: Evidence that the applicant has capacity, productivity, and institutional backing to complete and disseminate the research.
RPB offers awards tailored to different career stages and research profiles, including:
Career Development Award (for promising early-career faculty),
Physician-Scientist Award (for clinician researchers),
Stein Innovation Award (for high-risk, high-gain projects),
Medical Student Eye Research Fellowship (MSERF) (for MD students),
International Research Collaborators Award (for U.S.–international partnerships).RPB USA
Predictor: Correctly choosing the grant mechanism that fits the applicant’s experience and project scope improves competitiveness.
For department-level grants like Unrestricted Grants or Challenge Grants, predictors of success include:
A strong existing eye research portfolio,
A mature research environment,
Leadership from department chairs committed to eye research growth,
Institutional commitment (e.g., matching funds for Challenge Grants).RPB USA+1
Predictor: Demonstrating that the department has foundation (e.g., NIH awards) and strategic vision for eye research.
Awards such as the Stein Innovation Award explicitly aim to fund cutting-edge, unconventional research that might otherwise struggle to get funded. Projects should propose high-risk, high-reward ideas with strong justification and plausible impact pathways.RPB USA
Predictor: A bold, innovative concept with clear rationale and potential to transform understanding or treatment of eye disease.
RPB supports research across many diseases that threaten vision — from AMD, glaucoma, and retinal dystrophies to amblyopia and myopia. Funded topics often include those with a high public health burden or scientific opportunity.Newswise
Predictor: Projects that address vision-threatening conditions with significant unmet research needs are more compelling.
The International Research Collaborators Award demonstrates that internationally partnered projects can be competitive, especially when they promise geography-wide impact and knowledge exchange.RPB USA
Predictor: Thoughtful, well-structured international collaborations with clear roles and benefits.
RPB uses nomination and application procedures managed through department chairs (for some individual awards), with set deadlines in the spring and fall grant cycles. Complete, compliant applications with all required letters and documents are essential.RPB USA
Predictor: Timely, complete submissions that follow all instructions.
Misalignment with vision research focus: Proposals that do not clearly address eye disease mechanisms or vision outcomes are unlikely to be funded.
Poor match to award type: Applying to a mechanism that doesn’t fit the applicant’s career stage or scientific maturity.
Lack of institutional support: Especially for department grants, weak departmental engagement or inadequate infrastructure reduces chances.
Insufficient innovation or rationale: Projects that are incremental, descriptive, or poorly justified rank lower.
| Predictor | Typical Importance |
|---|---|
| Mission alignment with eye research | Essential |
| Scientific excellence & strong methods | High |
| Appropriate mechanism for career stage | High |
| Institutional support & environment | High |
| Innovation and potential impact | High (especially for Stein/Innovation) |
| Clear disease relevance | High |
| International collaboration (if relevant) | Medium |
| Compliance with guidelines and process | Essential |
Candidates in either cycle must be either MDs, PhDs, MD/PhDs or equivalent doctoral degree with an academic position of Associate Professor through full Professor. Candidates must provide not less than 5% effort for the proposed research.
Department chairs (including interim or acting chairs) can nominate multiple candidates per department per school. Though multiple candidates can be nominated, only one award per department can be approved.
Sponsor Institute/Organizations: Research to Prevent Blindness
Sponsor Type: Corporate/Non-Profit
Address: 360 Lexington Avenue, 22nd Floor New York, NY 10017
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
15-Dec-2025 [LOI/Pre-App], 10-Jan-2026 , 15-Jun-2026 [LOI/Pre-App], 01-Jul-2026
$300,000
Affiliation: Research to Prevent Blindness
Address: 360 Lexington Avenue, 22nd Floor New York, NY 10017
Website URL: https://www.rpbusa.org/grants/stein-innovation-award/
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.